Rare disease drug pioneer at Genzyme turns focus to schizophrenia (Video)

Last year, Rogerio Vivaldi’s career made an about face in more ways than one. After 20 years at local drug giant Genzyme, Vivaldi was head of that company’s unparalleled rare diseases unit, reporting directly to CEO David Meeker...